Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Allogene Therapeutics to Present Data from its Anti-CD19 AlloCAR T™ Therapy Program in .
Allogene Therapeutics, Inc.April 28, 2021 GMT
Longer Term Data from the ALLO-501 Phase 1 ALPHA Study to be Presented Alongside Initial Data from the Phase 1 ALLO-501A ALPHA2 Study
Separate Presentation to Include Safety and PK/PD Data on ALLO-647 Used in, Allogene’s Proprietary Lymphodepletion Regimen
ALLO-501A, Intended for a Potentially Pivotal Phase 2 Trial, Previously Granted FDA Fast Track Designation for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Allogene to Host Virtual CD19 Forum to Review ASCO Datasets on May 19, 2021 at 2:30 p.m. PT/5:30 p.m. ET
Orthofix Announces Exclusive US License for IGEA s Bone and Joint Stimulation Devices streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Health brief: Whitecar honored by National Cancer Research Association
By Special to The Dispatch 7 hours ago
John P. Whitecar
COLUMBUS Columbus oncologist Dr. John P. Whitecar, Jr. has been recognized for his 50 years of dedication to cancer research and membership in the American Association for Cancer Research (AACR).
The AACR is the world’s oldest and largest professional association related to cancer research. Based in Philadelphia, the AACR focuses on all aspects of cancer research, including basic, clinical, and translational research into the etiology, prevention, diagnosis, and treatment of cancer.
Whitecar was one of 32 members of the association who were inducted into the 50-year member ranks during the association’s annual meeting in early April. He is currently in practice at Baptist Cancer Center – Golden Triangle and he has been on staff at Baptist Memorial Hospital – Golden Triangle since 1997.
HMP Global Announces Distinguished Faculty Lineup for Inaugural Great Debates & Updates in Women’s Oncology
Share Article
Program features clinical insight from prominent experts in the fields of gynecological and breast cancers; two-day agenda will address hot topics in an interactive, engaging format
“Delivered in the highly popular and uniquely interactive Great Debates & Updates format, this program will offer participants an engaging, educational opportunity,” said Kathleen N. Moore, MD, MS, and Conference Co-Chair of GDU Women’s Oncology. MALVERN, Pa. (PRWEB) April 14, 2021 HMP Global, a leading healthcare event and education company, today announced the agenda and faculty lineup for its inaugural Great Debates & Updates in Women’s Oncology, taking place online April 23-24 via the company’s VRTX virtual events platform. The meeting’s faculty is comprised of a distinguished lineup of accomplis